The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kotov S.V.

Vladimirsky Moscow Regional Research Clinical Institute

Borisova V.A.

Vladimirsky Moscow Regional Research Clinical Institute

Slyunkova E.V.

Vladimirsky Moscow Regional Research Clinical Institute

Isakova E.V.

Vladimirsky Moscow Regional Clinical Research Institute

Kiselev A.V.

Semenov Institute of Chemical Physics

Kotov A.S.

Vladimirsky Moscow Regional Research Clinical Institute

Dynamics of recovery of cognitive deficit in patients in the early recovery period of ischemic stroke

Authors:

Kotov S.V., Borisova V.A., Slyunkova E.V., Isakova E.V., Kiselev A.V., Kotov A.S.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(11): 26‑32

DOI: 10.17116/jnevro202112111126

Read: 3034 times

Download PDF (RU)
Contact the author
Table of contents

DYNAMICS OF RECOVERY OF COGNITIVE DEFICIT IN PATIENTS IN THE EARLY RECOVERY PERIOD OF ISCHEMIC STROKE
DYNAMICS OF RECOVERY OF COGNITIVE DEFICIT IN PATIENTS IN THE EARLY RECOVERY PERIOD OF ISCHEMIC STROKE

To cite this article:

Kotov SV, Borisova VA, Slyunkova EV, Isakova EV, Kiselev AV, Kotov AS. Dynamics of recovery of cognitive deficit in patients in the early recovery period of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(11):26‑32. (In Russ.)
https://doi.org/10.17116/jnevro202112111126

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Sequential use of botu­linum toxin A and bovhyaluronidase azoximer in the correction of post-stroke spasticity. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):80-85
Cognitive vascular diso­rders and morphometric para­meters of the prefrontal, dorsolateral cortex and thalamus in post-stroke patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):91-95
Effe­ctiveness of comprehensive reha­bilitation of patients after a stroke in terms of changes in clinical and functional characteristics. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3-2):11-16
Nutrition correction in the complex therapy and reha­bilitation of the posttraumatic stress diso­rder. Russian Journal of Preventive Medi­cine. 2025;(2):114-119
Digi­tal dental approach in reha­bilitation of a patient treated for unilateral anky­losis of a temporomandibular joint using condylotomy. Stomatology. 2025;(1):9-16
An inte­grated approach to reha­bilitation of patients with chemotherapy-induced poly­neuropathy. Current state of the problem. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2025;(1):34-45
Hand burns in pediatrics. Piro­gov Russian Journal of Surgery. 2025;(3):96-106
Possibilities of vibroacoustic therapy application in patients with chro­nic bronchopulmonary pathology. Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(1):12-18
Reha­bilitation of patients with post-COVID syndrome depe­nding on C(159)T poly­morphism of SD-14 gene. Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(1):42-50
Effe­ctiveness of muscles’ preoperative preparation for reco­nstruction of ante­rior cruciate liga­ment of knee. Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(1):51-57
Abstract:

OBJECTIVE

Study of the effectiveness of the use of the drug Ampasse in the process of complex rehabilitation in patients in the early recovery period of ischemic stroke at the second (stationary) stage.

MATERIAL AND METHODS

The study included 60 patients, 28 women and 32 men, aged 43 to 76 years (mean — 58.4±9.1 years), in the recovery period after suffering a stroke in the period from 1 to 12 months (on average — 4.7±3.5 months). All patients received complex rehabilitation, patients of the 1st group received additional intravenous injections of the drug Ampasse 25 mg (5.0 ml), 15 injections. Patients of the 2nd group (n 0) did not receive Ampasse. To assess cognitive functions, the following tests were used: the Montreal Cognitive Assessment Scale (MoCA), Stroop’s test, subtest 9 of the Wechsler test, Koos cubes (CC), the severity of anxiety and depression was assessed, and motor recovery was assessed by the hand motor activity test (ARAT). The assessment was carried out before the start of treatment and on the 21st day.

RESULTS

There was a statistically significant increase in the score on the MoCA scale, in patients of the 1st group by an average of 2 points, in the 2nd group there was no significant dynamics, a statistically significant difference was found in the proportion of patients who had an increase in the MoCA index after the course of treatment in the 1st group. compared with the 2nd (χ2 — 22.528, p<0.001). Decreased the level of rigidity according to the Stroop test in patients of the 1st group compared with the 2nd (χ2 — 8.297, p=0.004). The number of patients who showed positive dynamics in the Koos cubes test in the 1st group was statistically significantly higher (χ2— 4.344, p=0.038). A statistically significant decrease in the level of depression was revealed in patients of the 1st group. The number of patients with improved motor function of the hand was greater in the 1st group of MG (χ2 — 4.286, p<0.039).

CONCLUSION

In patients in complex therapy receiving intravenous administration of the drug Ampasse at a dose of 25 mg (5.0 ml) 15 administrations, a statistically significant improvement in cognitive functions was revealed according to MoCA tests, Stroop test, Koos Cubes, when compared with the comparison group. The use of Ampasse increased the effectiveness of cognitive and motor rehabilitation in patients with post-stroke disorders.

Keywords:

acute ischemic stroke
rehabilitation
rehabilitation treatment
Ampasse

Authors:

Kotov S.V.

Vladimirsky Moscow Regional Research Clinical Institute

Borisova V.A.

Vladimirsky Moscow Regional Research Clinical Institute

Slyunkova E.V.

Vladimirsky Moscow Regional Research Clinical Institute

Isakova E.V.

Vladimirsky Moscow Regional Clinical Research Institute

Kiselev A.V.

Semenov Institute of Chemical Physics

Kotov A.S.

Vladimirsky Moscow Regional Research Clinical Institute

Received:

15.10.2021

Accepted:

13.11.2021

Close metadata

References:

  1. GBD 2016 Neurology Collaborators. Global, regional, and national burden of neurological disorders, 1990—2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(5):459-480.  https://doi.org/10.1016/S1474-4422(18)30499-X
  2. Sun JH, Tan L, Yu JT. Post-stroke cognitive impairment: epidemiology, mechanisms and management. Ann Transl Med. 2014;2(8):80-99.  https://doi.org/10.3978/j.issn.2305-5839.2014.08.05
  3. Kalaria RN, Akinyemi R, Ihara M. Stroke injury, cognitive impairment and vascular dementia. Biochim Biophys Acta. 2016;1862(5):915-925.  https://doi.org/10.1016/j.bbadis.2016.01.015
  4. Pendlebury ST, Rothwell PM; Oxford Vascular Study. Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study. Lancet Neurol. 2019;18(3):248-258.  https://doi.org/10.1016/S1474-4422(18)30442-3
  5. Yao YY, Wei ZJ, Zhang YC, et al. Functional Disability After Ischemic Stroke: A Community-Based Cross-Sectional Study in Shanghai, China. Front Neurol. 2021;12:649088. https://doi.org/10.3389/fneur.2021.649088
  6. Jokinen H, Melkas S, Ylikoski R, et al. Post-stroke cognitive impairment is common even after successful clinical recovery. Eur J Neurol. 2015;22(9):1288-1294. https://doi.org/10.1111/ene.12743
  7. Gorelick PB, Scuteri A, Black SE, et al. American Heart Association Stroke Council, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on Cardiovascular Radiology and Intervention, and Council on Cardiovascular Surgery and Anesthesia. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011;42(9):2672-2713. https://doi.org/10.1161/STR.0b013e3182299496
  8. Zhan M, Sun L, Liu J, et al. EGb in the Treatment for Patients with VCI: A Systematic Review and Meta-Analysis. Oxid Med Cell Longev. 2021;2021:8787684. https://doi.org/10.1155/2021/8787684
  9. Battle CE, Abdul-Rahim AH, Shenkin SD, et al.Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis. Cochrane Database Syst Rev. 2021;2(2):CD013306. https://doi.org/10.1002/14651858.CD013306.pub2
  10. McShane R, Westby MJ, Roberts E, et al. Memantine for dementia. Cochrane Database Syst Rev. 2019;3(3):CD003154. https://doi.org/10.1002/14651858.CD003154.pub6
  11. Lewerenz J, Maher P. Chronic Glutamate Toxicity in Neurodegenerative Diseases-What is the Evidence? Front Neurosci. 2015;9:469.  https://doi.org/10.3389/fnins.2015.00469
  12. Granzotto A, Canzoniero LMT, Sensi SL. A Neurotoxic Ménage-à-trois: Glutamate, Calcium, and Zinc in the Excitotoxic Cascade. Front Mol Neurosci. 2020;13:600089. https://doi.org/10.3389/fnmol.2020.600089
  13. Song X, Jensen MØ, Jogini V, et al. Mechanism of NMDA receptor channel block by MK-801 and memantine. Nature. 2018;556(7702):515-519.  https://doi.org/10.1038/s41586-018-0039-9
  14. Kiselev AV, Vostrikova EV, Kalinina TS, Stovbun SV. Randomized double-blind placebo-controlled study of the efficacy and safety of ampasse in the treatment of chronic cerebral ischemia. Journal of Neurology and Psychiatry named after S.S. Korsakov. 2019;119(4):21-25. (In Russ.). https://doi.org/10.17116/jnevro201911904121
  15. Skoromets AA, Kotov SV, Voronkov PB, et at. Efficacy and safety of ampasse therapy: results of a randomized, double-blind, placebo-controlled trial in patients with chronic cerebrovascular accident. Journal of Neurology and Psychiatry named after C.C. Korsakov. 2021;121(5):26-32. (In Russ.). https://doi.org/10.17116/jnevro202112105126
  16. Shi D, Chen X, Li Z. Diagnostic test accuracy of the Montreal Cognitive Assessment in the detection of post-stroke cognitive impairment under different stages and cutoffs: a systematic review and meta-analysis. Neurol Sci. 2018;39(4):705-716.  https://doi.org/10.1007/s10072-018-3254-0
  17. Periáñez JA, Lubrini G, García-Gutiérrez A, et al. Construct Validity of the Stroop Color-Word Test: Influence of Speed of Visual Search, Verbal Fluency, Working Memory, Cognitive Flexibility, and Conflict Monitoring. Arch Clin Neuropsychol. 2021;36(1):99-111.  https://doi.org/10.1093/arclin/acaa034
  18. Wisdom NM, Mignogna J, Collins RL. Variability in Wechsler Adult Intelligence Scale-IV subtest performance across age. Arch Clin Neuropsychol. 2012;27(4):389-397.  https://doi.org/10.1093/arclin/acs041
  19. Clinciu AI. A New Block Design Test: An Exploratory Study. Procedia — Social and Behavioral Sciences. 2015;187:369-373.  https://doi.org/10.1016/j.sbspro.2015.03.069
  20. Herrmann C. International experiences with the Hospital Anxiety and Depression Scale-a review of validation data and clinical results. J Psychosom Res. 1997;42(1):17-41.  https://doi.org/10.1016/s0022-3999(96)00216-4
  21. Ilut S, Stan A, Blesneag A, Vacaras V, et al. Factors that influence the severity of post-stroke depression. J Med Life. 2017;10(3):167-171. 
  22. Lyle RC. A performance test for assessment of upper limb function in physical rehabilitation treatment and research. Int J Rehabil Res. 1981;4(4):483-492.  https://doi.org/10.1097/00004356-198112000-00001
  23. Narasimhalu K, Ang S, De Silva DA, et al. Severity of CIND and MCI predict incidence of dementia in an ischemic stroke cohort. Neurology. 2009;73(22):1866-1872. https://doi.org/10.1212/WNL.0b013e3181c3fcb7
  24. Marei HE, Hasan A, Rizzi R, et al. Potential of Stem Cell-Based Therapy for Ischemic Stroke. Front Neurol. 2018;9:34-39.  https://doi.org/10.3389/fneur.2018.00034
  25. Szelenberger R, Kostka J, Saluk-Bijak J, Miller E. Pharmacological Interventions and Rehabilitation Approach for Enhancing Brain Self-repair and Stroke Recovery. Curr Neuropharmacol. 2020;18(1):51-64.  https://doi.org/10.2174/1570159X17666190726104139
  26. Coleman ER, Moudgal R, Lang K, et al. Early Rehabilitation After Stroke: a Narrative Review. Curr Atheroscler Rep. 2017;19(12):59-64.  https://doi.org/10.1007/s11883-017-0686-6
  27. Farooq MU, Min J, Goshgarian C, Gorelick PB. Pharmacotherapy for Vascular Cognitive Impairment. CNS Drugs. 2017;31(9):759-776.  https://doi.org/10.1007/s40263-017-0459-3
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.